BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6198969)

  • 21. [Results of a combination of platinum-vindesin-ametycin-bleomycin (CEMB) in the treatment of stage IV non-small-cell lung cancers].
    Souquet PJ; Fournel P; Jorda M; Laennec E; Piperno D; Trillet V; Rebattu P; Bernard JP
    Bull Cancer; 1993 Jan; 80(1):80-2. PubMed ID: 7515730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
    Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
    Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of mesopharyngeal carcinoma that showed a complete response to induction chemotherapy].
    Tsuruta Y; Miyahara H; Sato T; Yoshino K; Umatani K
    Gan No Rinsho; 1988 Oct; 34(12):1693-8. PubMed ID: 2461455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
    Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
    Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide].
    Chauvergne J; Héron JF; Mayer F; Charrot-Chinet P; Toulouse C
    Bull Cancer; 1993 Jan; 80(1):70-9. PubMed ID: 7515729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of recurrent small cell lung carcinoma with vindesine and cisplatin.
    Niederle N; Schütte J; Schmidt CG; Seeber S
    Cancer Treat Rep; 1984 May; 68(5):791-2. PubMed ID: 6327037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adriamycin and cis-dichlorodiammineplatinum in nonresectable and metastatic carcinoma of the lung.
    Morris RW; Brubaker LH; Kardinal CG; Carolla RL; Perry MC
    Cancer Clin Trials; 1979; 2(1):37-41. PubMed ID: 229982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy for advanced adenocarcinoma and squamous cell carcinoma of the lung with etoposide and cisplatin.
    Dhingra HM; Valdivieso M; Booser DJ; Umsawasdi T; Carr DT; Chiuten DF; Murphy WK; Issell BF; Spitzer G; Farha P
    Cancer Treat Rep; 1984 Apr; 68(4):671-3. PubMed ID: 6538811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.
    Krook JE; Fleming TR; Eagan RT; Cullinan S; Pfeifle D; Elliott T; Etzell P
    Cancer Treat Rep; 1984 Mar; 68(3):493-8. PubMed ID: 6322987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cisplatin, etoposide, and vincristine combination chemotherapy in the treatment of non-small cell lung cancer.
    Watanabe A; Ichiyama S; Shimokata K; Nagura E; Saito H; Saka H; Nomura F; Sakai S; Saito H
    Nagoya J Med Sci; 1993 Mar; 55(1-4):41-6. PubMed ID: 8247105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of advanced or recurrent squamous cell carcinoma of the uterine cervix with mitomycin-C, bleomycin, and cisplatin chemotherapy.
    Smith HO; Stringer CA; Kavanagh JJ; Gershenson DM; Edwards CL; Wharton JT
    Gynecol Oncol; 1993 Jan; 48(1):11-5. PubMed ID: 7678571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pilot study on induction chemotherapy with cisplatin, epirubicin, etoposide and bleomycin in cervical cancer stage Ib, IIa and IIb.
    Panetta A; Angelelli B; Martoni A
    Anticancer Res; 1999; 19(1B):765-8. PubMed ID: 10216490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The value of carcinoembryonic antigens in patients with advanced lung cancer: in relation to chemotherapy].
    Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Takahashi K; Sasaki Y; Ohkura H
    Gan To Kagaku Ryoho; 1984 May; 11(5):1056-63. PubMed ID: 6202246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase II study of neoadjuvant chemotherapy with cisplatin epirubicin and VP-16 for stage III unresectable non-small cell lung cancer.
    Iacobelli S; Irtelli L; Sacco R; Martino M; Mascitelli E; Basilico L; Scognamiglio M; Natoli C; Fusco O; Tinari N; Beltrami V
    Anticancer Res; 1998; 18(3B):2081-4. PubMed ID: 9677471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.